Actimmune (interferon gamma-1b subcutaneous injection – Horizon) — Cigna

Initial criteria

• Diagnosis has been established by a molecular genetic test identifying a gene-related pathogenic variant linked to chronic granulomatous disease; AND
• The medication is prescribed by or in consultation with an immunologist, a hematologist, or an infectious disease specialist.

Approval duration

1 year